Table 12.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Lung Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 72 320 601 2,088 794 1,455 9 4 19 244 5,606
% of All Regimens 1.3% 5.7% 10.7% 37.2% 14.2% 26.0% 0.2% 0.1% 0.3% 4.4% 100.0%
Induction Drug 2.8% 3.8% 1.2% 7.4% 5.7% 4.1% 0.0% 0.0% 5.3% 13.9% 5.6%
Atgam/NRATG/NRATS
OKT3 2.8% 0.0% 1.7% 0.1% 4.2% 0.1% 0.0% 0.0% 0.0% 2.5% 1.0%
Thymoglobulin 5.6% 2.2% 3.2% 5.3% 6.8% 1.7% 11.1% 0.0% 5.3% 14.3% 4.6%
Zenapax 1.4% 3.1% 15.6% 17.4% 8.7% 16.6% 22.2% 0.0% 10.5% 36.5% 15.5%
Simulect 5.6% 4.4% 16.5% 19.6% 12.8% 31.1% 33.3% 50.0% 63.2% 48.4% 21.7%
Campath 2.8% 15.0% 0.2% 6.9% 0.0% 0.1% 0.0% 0.0% 5.3% 9.4% 3.9%
No Induction Drugs Recorded 79.2% 71.9% 62.1% 44.0% 62.8% 46.9% 33.3% 50.0% 15.8% 59.8% 52.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.